Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Tissue Preparation Solution Enables Increased Efficiency for Molecular Pathology Laboratories

By LabMedica International staff writers
Posted on 27 Nov 2013
A new tissue preparation system now enables automated extraction of high-quality nucleic acids from fresh frozen tissues as well as from formalin-fixed paraffin embedded (FFPE) tissues. More...


Siemens Healthcare Sector (Malvern, PA, USA) now offers its “Tissue Preparation Solution,” which includes a Tissue Preparation System and the Versant Tissue Preparation Reagents kit. Fresh frozen (FF) tissues are typically used for quick diagnosis of patients undergoing surgery, for research, or for tissue collection and storage. Formalin-fixed, paraffin embedded tissue clinical samples are routinely prepared from tissues obtained from surgeries and biopsies. FF tissue samples usually require separate workflows and specific kits not compatible with FFPE tissues, making the integration of these two processes a challenge for molecular pathology labs. Now, the consolidation of both tissue types on the Siemens Tissue Preparation Solution provides the only automated solution currently available for standardized isolation of nucleic acids from both FF and FFPE tissue samples such as those obtained for in vitro diagnosis and research.

Before the introduction of this Siemens solution, laboratories were limited to systems that were either manual or only automated for certain steps of the process. “When compared to other manual and semi-automated procedures, the Siemens method really sets a new standard in quality and workflow efficiency for routine molecular pathology laboratories,” commented Manfred Dietel, MD, Director of Institute of Pathology, University Hospital, Charité Berlin (Germany).

Using magnetic particle-based isolation and proprietary bead technology, this solution provides a more efficient and reproducible process for the isolation of high-quality nucleic acids from FFPE tissue. It features an automated process including the integration of deparaffinization; eliminates centrifugation steps associated with deparaffinization; enables coextraction of DNA and RNA from a single extraction process with a single set of reagents; provides a standardized lysis step for all samples; delivers highly reproducible results; and processes up to 48 samples in about 4 hours. Laboratory safety and environmental quality are also enhanced as hazardous organic solvents are eliminated with the deparaffinization process.

Related Links:

Siemens Healthcare



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.